Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2865307 | The American Journal of the Medical Sciences | 2007 | 9 Pages |
Abstract
A higher APACHE II score at admission and a higher frequency of coexisting malignancy may have contributed to the higher, although not significant, mortality rate in patients with liver abscess caused by E coli infection. Clinicians should begin with broad antibiotic coverage such as a second-generation cephalosporin and an aminoglycoside with metronidazole when treating liver abscesses with E coli as the likely pathogen due to the high frequency of multi-drug-resistant isolates among E coli isolates.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Shiuan-Chih MD, PhD, Wei-Ya MD, MSc, Kuang-Chi MD, PhD, Meng-Chih MD, PhD, MPH, Po-Hui MD, PhD, Chun-Chieh MD, MSc, Ding-Bang PhD, Chung-Hsin MD, MSc, Long-Bin MD, Ken-Sheng MD, William R. PhD, MD,